{
  "docId": "019de075-3c48-75dd-a16f-ddcce5fecf48",
  "docSlug": "20dccf7a034b09514201ed73755b4bbb",
  "documentTitle": "Absci | Investor Presentation Deck | 48 slides",
  "authorId": "absci",
  "authorName": "Absci",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 48,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "why_now",
  "function": "frame_problem",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "Uses a visual comparison between small molecule and biologic data availability to frame the problem.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-3c48-75dd-a16f-ddcce5fecf48/5",
  "deckHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48",
  "deckJsonHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48.json",
  "deckAnchorHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.4,
        "w": 0.9,
        "x": 0.06,
        "y": 0.45
      },
      "kind": "image",
      "text": "Comparison of small molecule vs biologic data availability",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "75b2936a-3ae9-4241-97ae-c13e96f6333e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.25,
        "x": 0.37,
        "y": 0.48
      },
      "kind": "paragraph",
      "text": "Biologics require living organisms to produce drug variants for testing",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "23d771b6-0f69-455f-b19f-8dee73799c29",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.25,
        "x": 0.72,
        "y": 0.48
      },
      "kind": "paragraph",
      "text": "Unlocking the potential of generative AI in biology... requires generating scalable biological data",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "55e05e7d-02d0-4502-ae79-75fe6b1943ce",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.15,
        "x": 0.09,
        "y": 0.48
      },
      "kind": "paragraph",
      "text": "Small Molecule v. Biologic",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ad717867-58ca-4fa8-83cd-ab8a6cb3bf16",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.8,
        "x": 0.06,
        "y": 0.12
      },
      "kind": "title",
      "text": "Unlocking the potential of generative AI in biology requires scalable biological data",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "85d75ee9-1f4c-4633-930d-45e8278ebfad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.06,
        "y": 0.05
      },
      "kind": "title",
      "text": "WHY HASN'T GENERATIVE AI TRANSFORMED BIOLOGIC DRUG DISCOVERY?",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5d68d816-1c0e-4484-95a3-873779c6b4c1",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Problem Statement Canvas",
      "slug": "problem-statement-canvas",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "4c00a0ea-c4f6-4b7f-a1e6-8328a36f3489",
      "evidence": "The slide presents a problem statement, 'WHY HASN'T GENERATIVE AI TRANSFORMED BIOLOGIC DRUG DISCOVERY?'",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "problem-solution-gap",
      "slug": null,
      "matchId": "1af695c1-b534-493e-a3bb-ee70bc811a8c",
      "evidence": "Contrasts current data limitations with the requirement for AI success",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 5,
      "from": 5,
      "beatId": "4f434aff-bbad-4d99-93fa-1b93ec660ac6",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Agitate",
      "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
      "evidence": "Slide 5 emphasizes the need for disruption in biologic drug discovery",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [
    {
      "to": 5,
      "from": 3,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "22856dcb-1ef7-4e6e-8902-fe45270c2065",
      "evidence": "Slides 3-5 highlight the inefficiency of current drug discovery processes and the need for disruption",
      "position": 0,
      "objective": "What if the current drug discovery process continues to be inefficient?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}